ATE519510T1 - Antithrombogene und antirestenotische vaskuläre medizinprodukte - Google Patents

Antithrombogene und antirestenotische vaskuläre medizinprodukte

Info

Publication number
ATE519510T1
ATE519510T1 AT05810457T AT05810457T ATE519510T1 AT E519510 T1 ATE519510 T1 AT E519510T1 AT 05810457 T AT05810457 T AT 05810457T AT 05810457 T AT05810457 T AT 05810457T AT E519510 T1 ATE519510 T1 AT E519510T1
Authority
AT
Austria
Prior art keywords
antirestenotic
antithrombogenic
medical devices
vascular medical
medical device
Prior art date
Application number
AT05810457T
Other languages
English (en)
Inventor
Robert Herrmann
Original Assignee
Boston Scient Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boston Scient Ltd filed Critical Boston Scient Ltd
Application granted granted Critical
Publication of ATE519510T1 publication Critical patent/ATE519510T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A61L31/10—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/114—Nitric oxide, i.e. NO
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/606—Coatings
    • A61L2300/608—Coatings having two or more layers
    • A61L2300/61—Coatings having two or more layers containing two or more active agents in different layers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Vascular Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Prostheses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT05810457T 2004-10-29 2005-10-12 Antithrombogene und antirestenotische vaskuläre medizinprodukte ATE519510T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/977,695 US8388677B2 (en) 2004-10-29 2004-10-29 Anti-thrombogenic and anti-restenotic vascular medical devices
PCT/US2005/036622 WO2006049823A2 (en) 2004-10-29 2005-10-12 Anti-thrombogenic and anti-restenotic vascular medical devices

Publications (1)

Publication Number Publication Date
ATE519510T1 true ATE519510T1 (de) 2011-08-15

Family

ID=36169164

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05810457T ATE519510T1 (de) 2004-10-29 2005-10-12 Antithrombogene und antirestenotische vaskuläre medizinprodukte

Country Status (6)

Country Link
US (1) US8388677B2 (de)
EP (1) EP1809346B1 (de)
JP (1) JP2008517715A (de)
AT (1) ATE519510T1 (de)
CA (1) CA2585481A1 (de)
WO (1) WO2006049823A2 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8017074B2 (en) 2004-01-07 2011-09-13 Noxilizer, Inc. Sterilization system and device
WO2005067986A1 (en) * 2004-01-07 2005-07-28 Noxilizer, Inc. Sterilization system and device
EP1888510A4 (de) 2005-05-27 2013-01-16 Univ North Carolina Stickoxidfreisetzende partikel für stickoxidtherapeutika und biomedizinische anwendungen
US20070135908A1 (en) * 2005-12-08 2007-06-14 Zhao Jonathon Z Absorbable stent comprising coating for controlling degradation and maintaining pH neutrality
US8956640B2 (en) * 2006-06-29 2015-02-17 Advanced Cardiovascular Systems, Inc. Block copolymers including a methoxyethyl methacrylate midblock
US20080008736A1 (en) * 2006-07-06 2008-01-10 Thierry Glauser Random copolymers of methacrylates and acrylates
US8679519B2 (en) * 2007-10-23 2014-03-25 Abbott Cardiovascular Systems Inc. Coating designs for the tailored release of dual drugs from polymeric coatings
US10028747B2 (en) 2008-05-01 2018-07-24 Aneuclose Llc Coils with a series of proximally-and-distally-connected loops for occluding a cerebral aneurysm
US10716573B2 (en) 2008-05-01 2020-07-21 Aneuclose Janjua aneurysm net with a resilient neck-bridging portion for occluding a cerebral aneurysm
US20100063578A1 (en) * 2008-09-05 2010-03-11 Aga Medical Corporation Bifurcated medical device for treating a target site and associated method
EP2361099B1 (de) 2009-02-23 2012-09-12 Noxilizer, Inc. Verfahren zur gassterilisation
BR112012003792B1 (pt) 2009-08-21 2020-05-19 Novan Inc composição tópica, e, uso da composição tópica
BR112012003804B1 (pt) 2009-08-21 2019-02-19 Novan, Inc. Curativo para ferimentos, método para formar um curativo para ferimentos, e, kit de curativo para ferimento
US9358140B1 (en) 2009-11-18 2016-06-07 Aneuclose Llc Stent with outer member to embolize an aneurysm
ES2695173T3 (es) 2011-02-28 2019-01-02 Novan Inc Partículas de sílice modificadas con S-nitrosotiol que liberan óxido nítrico y procedimientos de fabricación de las mismas
US9187501B2 (en) 2012-08-28 2015-11-17 The University Of North Carolina At Chapel Hill Nitric oxide-releasing nanorods and their methods of use
WO2014165023A1 (en) 2013-03-12 2014-10-09 Carnegie Mellon University Coated vaso-occclusive device for treatment of aneurysms

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5811447A (en) 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6545097B2 (en) * 2000-12-12 2003-04-08 Scimed Life Systems, Inc. Drug delivery compositions and medical devices containing block copolymer
US6780849B2 (en) 2000-12-21 2004-08-24 Scimed Life Systems, Inc. Lipid-based nitric oxide donors
US6706274B2 (en) 2001-01-18 2004-03-16 Scimed Life Systems, Inc. Differential delivery of nitric oxide
US6939376B2 (en) 2001-11-05 2005-09-06 Sun Biomedical, Ltd. Drug-delivery endovascular stent and method for treating restenosis
US20040002755A1 (en) 2002-06-28 2004-01-01 Fischell David R. Method and apparatus for treating vulnerable coronary plaques using drug-eluting stents
JP4588986B2 (ja) 2002-08-20 2010-12-01 テルモ株式会社 体内埋込医療器具
JP2004267283A (ja) 2003-03-05 2004-09-30 Terumo Corp 体内埋込医療材料および体内埋込医療器具
US20050220835A1 (en) * 2004-03-30 2005-10-06 Jayaraman Ramesh B Agent eluting bioimplantable devices and polymer systems for their preparation
US20060039950A1 (en) * 2004-08-23 2006-02-23 Zhengrong Zhou Multi-functional biocompatible coatings for intravascular devices

Also Published As

Publication number Publication date
JP2008517715A (ja) 2008-05-29
WO2006049823A2 (en) 2006-05-11
WO2006049823A3 (en) 2006-06-22
US8388677B2 (en) 2013-03-05
US20060095120A1 (en) 2006-05-04
CA2585481A1 (en) 2006-05-11
EP1809346A2 (de) 2007-07-25
EP1809346B1 (de) 2011-08-10

Similar Documents

Publication Publication Date Title
ATE519510T1 (de) Antithrombogene und antirestenotische vaskuläre medizinprodukte
DE602004022834D1 (de) Biologisch absorbierbare überzüge für implantierbare vorrichtungen
ATE389423T1 (de) Beschichtungen für implantierbare vorrichtungen enthaltend blockcopolymeren aus milchsäure und ethylenglykol
WO2006014607A3 (en) Medical devices containing radiation resistant block copolymer
ATE460437T1 (de) Polymere von fluormonomeren und hydrophilen monomeren
WO2006023130A3 (en) Biodegradable controlled release bioactive agent delivery device
AR041562A1 (es) Preparacion de liberacion controlada
MXPA05011703A (es) Forma de dosis transdermica resistente a los retardadores que comprende un componente de agente activo y un componente de agente adverso en el sitio distal de la capa del agente activo.
PT1251902E (pt) Dispositivo medico
ATE394134T1 (de) Kathetersperrlösung mit photo-oxidant
DE602005026016D1 (de) Beschichtungen für implantierbare vorrichtungen mit poly(hydroxy-alkanoaten) und disäure-bindungen
WO2007133518A3 (en) Modulating agents for antimicrobial coatings
WO2009042667A3 (en) Medical devices having a metal particulate composition for controlled diffusion
WO2006074391A3 (en) Biodegradable coating compositions comprising blends
DK1468703T3 (da) Implanterbar ortopædisk indretning
ATE354384T1 (de) Perkutane zugangsvorrichtung
WO2004080397A3 (en) Implantable or insertable medical devices containing miscible polymer blends for controlled delivery of a therapeutic agent
WO2005099621A3 (en) Topographic coatings and coating methods for medical devices
ATE494897T1 (de) Biokompatible multifunktionsbeschichtungen für intravaskuläre vorrichtungen
WO2004050140A3 (en) Medical devices for delivery of therapeutic agents
DE602004021285D1 (de) Wundverbände und verfahren
ATE546168T1 (de) Blutstillende zusammensetzung und vorrichtung
ATE353025T1 (de) Hämostatisches ventil
EP1733429A4 (de) Begrenzer und halbleitereinrichtung damit
WO2008134475A3 (en) Implant device release agents and methods of using same

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties